Vontobel Holding
TARS icon

Vontobel Holding’s Tarsus Pharmaceuticals TARS Stock Holding History

Vontobel Holding’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
40,000
+30,246
+310% +$1.93M 0.01% 589
2026
Q1 		$684K Buy
9,754
+910
+10% +$63.6K ﹤0.01% 744
2025
Q4 		$724K Buy
+8,844
New +$660K ﹤0.01% 863

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vontobel Holding's TARS Position: Q2 2026 in Review

Vontobel Holding increased its Tarsus Pharmaceuticals (TARS) stake by 310% in Q2 2026, buying an estimated $1.93M and bringing the position to 40,000 shares worth $2.52M. The position accounts for 0.01% of the portfolio, ranked #589.

Vontobel Holding first reported a position in TARS in Q4 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Vontobel Holding held 40,000 shares of Tarsus Pharmaceuticals worth $2.52M as of Q2 2026.
  • Vontobel Holding bought 30,246 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.93M.
  • Tarsus Pharmaceuticals made up 0.01% of Vontobel Holding's portfolio in Q2 2026, its #589 holding.
  • Vontobel Holding first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.